TGFB2 and glioblastoma: To identify prognostic gene markers, we screened the mRNA expression of 14,364 genes curated across 1272 Reactome pathways to identify consistently affected pathways, comparing young, old, and all GBM patients enriched with the expression of genes negatively correlated with TGFB2 methylation.